Brazil halts Sputnik V vaccine approval due to lack of data
Brazil's health regulator Anvisa has sent back documents seeking approval for emergency use of Russia's Sputnik V vaccine due to lack of Phase 3 trials data. It stated that emergency approval to any vaccine will be given only after proving its long-term safety and efficacy. The promoters of Sputnik V said that the required data will be provided to Anvisa.